Atria Investments LLC Abbott Laboratories Transaction History

Atria Investments LLC

$7.56 Billion
Q3 2024

A detailed history of Atria Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Atria Investments LLC holds 163,218 shares of ABT stock, worth $18.7 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

163,218

Previous 153,896 6.06%

Holding current value

$18.7 Million

Previous $16 Million 16.37%

% of portfolio

0.25%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $932,852 - $1.1 Million	9,322 Added 6.06%	163,218 $18.6 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $960,561 - $1.07 Million	-9,536 Reduced 5.83%	153,896 $16 Million
Q1 2024 May 21, 2024	BUY	$109.52 - $120.96 $1.66 Million - $1.83 Million	15,118 Added 10.19%	163,432 $18.6 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.59 Million - $1.95 Million	17,657 Added 13.51%	148,314 $16.3 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $350,690 - $420,770	-3,671 Reduced 2.73%	130,657 $12.7 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $1.21 Million - $1.34 Million	11,966 Added 9.78%	134,328 $14.6 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $855,370 - $1.01 Million	8,831 Added 7.78%	122,362 $12.4 Million
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $469,596 - $550,908	4,940 Added 4.55%	113,531 $12.5 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $712,637 - $825,100	7,365 Added 7.28%	108,591 $10.5 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $3.09 Million - $3.73 Million	-30,264 Reduced 23.02%	101,226 $11 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $1.24 Million - $1.51 Million	10,885 Added 9.03%	131,490 $15.6 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $1.81 Million - $2.22 Million	15,694 Added 14.96%	120,605 $17 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $1.83 Million - $2.02 Million	15,658 Added 17.54%	104,911 $12.4 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $797,762 - $939,080	7,541 Added 9.23%	89,253 $10.3 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $1.93 Million - $2.27 Million	17,723 Added 27.7%	81,712 $9.79 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $736,050 - $802,084	-7,010 Reduced 9.87%	63,989 $7.01 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $154,321 - $187,412	1,684 Added 2.43%	70,999 $7.73 Million
Q2 2020 Sep 22, 2020	SELL	$76.57 - $98.0 $4.15 Million - $5.31 Million	-54,226 Reduced 43.89%	69,315 $6.34 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $2.05 Million - $2.99 Million	-32,597 Reduced 20.88%	123,541 $9.75 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $3.08 Million - $3.42 Million	39,187 Added 33.51%	156,138 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $282,348 - $306,153	3,450 Added 3.04%	116,951 $9.79 Million
Q2 2019 Aug 26, 2019	BUY	$72.88 - $85.0 $8.27 Million - $9.65 Million	113,501 New	113,501 $9.71 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $4.33 Million - $5.24 Million	-65,449 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $166,194 - $188,274	-2,535 Reduced 3.73%	65,449 $4.73 Million
Q3 2018 Oct 09, 2018	SELL	$60.81 - $73.36 $39,161 - $47,243	-644 Reduced 0.94%	67,984 $4.99 Million
Q2 2018 Jul 13, 2018	BUY	$57.57 - $63.54 $265,109 - $292,601	4,605 Added 7.19%	68,628 $4.19 Million
Q1 2018 Apr 30, 2018	BUY	$56.27 - $63.62 $116,647 - $131,884	2,073 Added 3.35%	64,023 $3.84 Million
Q4 2017 Jan 16, 2018	BUY	$53.68 - $57.47 $315,208 - $337,463	5,872 Added 10.47%	61,950 $3.54 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $2.7 Million - $3.01 Million	56,078	56,078 $2.99 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Abbott Laboratories Transaction History